OBJECTIVES. Achieving Success in Reducing Inappropriate Use of Antipsychotic Medication in Patients with Dementia

Size: px
Start display at page:

Download "OBJECTIVES. Achieving Success in Reducing Inappropriate Use of Antipsychotic Medication in Patients with Dementia"

Transcription

1 Achieving Success in Reducing Inappropriate Use of Antipsychotic Medication in Patients with Dementia Amy J. Osborn, NHA, PMP Executive Director, Health Services Advisory Group (HSAG) Rick Foley, PharmD, CPh, CGP, FASCP, BCPP Clinical Professor of Geriatrics, University of Florida College of Pharmacy President, Florida Chapter - American Society of Consultant Pharmacists Maureen Brown, MSN, MBA, HCM Administrator, Miami Shores Nursing and Rehab Center August 10, 2016 OBJECTIVES Examine the potentially inappropriate use of antipsychotic medication in patients with dementia Integrate interventions to reduce the inappropriate use of antipsychotic drugs in patients with dementia Learn the key elements to include in an antipsychotic medication reduction QAPI plan 2 NATIONAL PARTNERSHIP TO IMPROVE DEMENTIA CARE Amy Osborn NHA, PMP Executive Director, Health Services Advisory Group (HSAG) Enrollment and Certification/SurveyCertificationGenInfo/National Partnership to Improve Dementia Care in Nursing Homes.html 3 1

2 GOAL FOR 2016: 30% OR GREATER REDUCTION What is your current rate? What percentage reduction has your center achieved? 4 Let s Compare! Partnership Results Florida Q Q Florida Reduction of 31.1% Nation Reduction of 28.8% Florida National Rank 35 of of 51 5 IMPROVING CARE AND QUALITY OF LIFE FOR PATIENTS WITH DEMENTIA IN LONG- TERM CARE Rick Foley, PharmD, CPh, CGP, FASCP, BCPP Consultant Pharmacist Omnicare Clinical Professor of Geriatrics UF College of Pharmacy President Florida Chapter American Society of Consultant Pharm 6 2

3 The Pharmacist s Perspective First do no harm The regulations Trends in the field Recognizing prescribing patterns that lead to antipsychotic (AP) use 7 First Do No Harm EPS 1 in 10 patients taking olanzapine, 1 in 20 with risperidone CVA 1 in 34 patients taking risperidone During week trials, 1 out of every 100 patients taking an atypical AP died accessed October Conventional and atypical antipsychotics appear to increase the risk of hospitalization for femur fracture in a population of institutionalized elderly patients. These medications should be used with caution, especially among patients with a high risk of falls Journal of Clinical Psychiatry 2007, 68 (6): Atypical antipsychotic drugs may be associated with a small increased risk for death compared with placebo JAMA: 2005 October 19, 294 (15): increase the risk of hospitalization The studies have also shown, however, a greater risk of mortality and adverse cerebrovascular events with several of these agents than with placebo in individuals with dementia Harv Rev Psychiatry Nov Dec;13(6): increased risk for death Our findings suggest that many older people with Alzheimer's dementia and NPS can be withdrawn from chronic antipsychotic medication without detrimental effects on their behaviour Neuropsychopharmacology April ; 33(5): doi: /sj.npp Among patients continuing phase 1 treatment at greater 12 weeks, risk there of mortality were no significant differences between antipsychotics and placebo on cognition, functioning, care needs, or quality of life American Journal of Psychiatry 2008, 165 (7):

4 F329 Unnecessary Drugs New concept May 2013 Individualized, person centered approaches that may help reduce potentially distressing or harmful behaviors and promote improved functional abilities and quality of life for residents Bottom line APs can only be used after ALL other causes of behavior have been ruled out 10 F329 - continued Requirements when using APs Diagnosis Target behaviors quantitative documentation each shift; specific guidance on TBs Dose limitations, unless documented rationale is present Daily monitoring of side effects Assessment of movement side effects at least every 6 months GDR twice within first year, in two separate quarters and separated by at least 1 month Contraindication requires significant rationale 11 Quarter CMS National Partnership for the Treatment of Dementia Initial antipsychotic use reduction set at 15% for 2012 National average reduction 15.1% New goal set to reduce by 25% by the end of 2015 and 30% by the end of 2016 Florida 31.1% (Q4 2015) Reinforces the concept of non pharmacologic approaches ALL regions achieved goal As of Q4 2015, Florida ranks 26th of 50 states + District of Columbia; Mississippi 51st at 20.5% Hawaii ranked #1 at 7.6% with a 39.3% reduction

5 Trends In The Field Microdosing of Quetiapine Potent binding and antagonism of H 1 and α 1 receptors Sedation, orthostasis, weight gain Side effects may be enhanced at low doses 25mg QHS for dementia sleep? 25mg QHS and my patient is falling! Blanket contraindication statements Preprinted progress notes Staff pushback on GDR despite documentation 13 Other Patterns Justifying admission orders Newly diagnosed schizophrenia at age 95? Benadryl from home? Must be itching, at HS Disregard of the geriatric demographic Ignoring ongoing prescribing cascades 14 Prescribing Cascades and Aps: A Real World Example New resident w/ dementia agitated MD called Behaviors become constant, patient moved to locked unit Resident is now disinhibited and falls Given 3x PRN Xanax New order for risperidone for BPSD Pt develops tremor PD diagnosed Sinemet ordered Midodrine ordered TID 3 weeks of behaviors Resident naps due to sedation Postural HA Sxs worsen Psychiatry consulted GDR clinically CI Risperdal increased 15 5

6 Prescribing Cascades Common Issues Limited information for practitioners Assuming disease manifestation Broad strokes with blank check orders Underestimation of drugs side effect potential and severity anticholinergic load Overestimation of efficacy of behavior meds prescribed Lack of zero budgeting drug regimen evaluation A method of prescribing in which medications must be justified for each new period. Zero based budgeting starts from a zero base and every treatment, goal of therapy, and expected and realistic patientfocused outcome, is analyzed for its appropriateness and risk benefit profile 16 Non Pharmacologic Approaches To Behaviors Avoid confrontation Remove environmental triggers Create calm, quiet environment (offer gentle help) Structure daily routine Address pain, discomfort Use aromatherapy Use scheduled or prompted toileting AMDA Multidisciplinary Medication Management Manual, American Medical Directors Association, March Antipsychotic Reduction Miami Shores Nursing and Rehabilitation Center Maureen Brown, RN, MSN, MBA Administrator 6

7 An Administrator s Approach Why should you take on this effort? Identify strategies that made our efforts successful What specific Interventions were implemented and integration with QAPI program Discuss the time it took accomplish our success Discuss some barriers faced and how we overcame them What are the actual facility wide results of the reduction Discuss the impact on the quality of life of our residents 2012 Facility Long-Term Quality Measure Rate 94% for antipsychotic medication utilization making the facility #1 in Florida. 20 Strategies that Made Our Efforts Successful Utilizing a Interdisciplinary Team Care Meetings Communication Champions of Care/Peer Coaches Support and Resources from FHCA & HSAG Involvement of Pharmacy 7

8 Integration Of Interventions In QAPI Program Tools used in QAPI program Plan Do Study Act Model Root Cause Analysis Assessments MDS data Consistent Assignment Person Centered Individualized Care Staff Education and Cross Training Music Therapy and Variety of Activities Examples Of Tools Used Examples of Tools Used (continued) 8

9 Examples of Tools Used (continued) How can we keep it going? Should we try a new plan? Did it work? What is our data? Act Plan PDSA Study Do What are we doing now? Is it a big problem? What can we try? Let s try our plan. Barriers Faced Physician cooperation and education Family cooperation and education Staff motivation/staff burn out Dealing with admissions and readmissions Alternatives options Staff turnover/staffing for individualized care Solutions That Worked To Maintain Reduced Antipsychotic Rates Must have designated gatekeeper addressing admissions (pre admission interviews with family) Your direct care staff needs assistance at the point of care so peer coaching is a great idea. Staffing has to be flexible based on care needs Take and interdisciplinary approach cannot be done by the nursing department only. Must educate all providers especially the physicians Person Centered Individualized Care 27 9

10 Long-term Care (LTC) Residents taking Antipsychotic Medications/Off-Label Use Percentage Q1 Q Q Q Florida Nation Source: CMS Minimum Data Set (MDS) Data LTC Residents taking Antipsychotic Medications/Off-Label Use: Miami Shores Percentage Q1 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1 Q Miami Shores Source: CMS Minimum Data Set (MDS) Data Impact On Quality of Life For Our Residents Resulted in a culture change in our facility that affected residents, family members, and staff in a positive way Drastic reduction in falls and accidents rates in our facility Facility saw improved outcomes in all our other quality measures indicators More engaged staff and improved resident/staff relationships Improved resident, family, and staff satisfaction Better Survey outcomes 10

11 Contact Information Maureen Brown Rick Foley Amy Osborn 31 11

Psychotropic Medication. Including Role of Gradual Dose Reductions

Psychotropic Medication. Including Role of Gradual Dose Reductions Psychotropic Medication Including Role of Gradual Dose Reductions What are they? The phrase psychotropic drugs is a technical term for psychiatric medicines that alter chemical levels in the brain which

More information

Debra Brown, PharmD, FASCP Pharmaceutical Consultant II Specialist. HMS Training Webinar January 27, 2017

Debra Brown, PharmD, FASCP Pharmaceutical Consultant II Specialist. HMS Training Webinar January 27, 2017 Debra Brown, PharmD, FASCP Pharmaceutical Consultant II Specialist HMS Training Webinar January 27, 2017 1 Describe nationwide prevalence and types of elderly dementia + define BPSD Define psychotropic

More information

Presented by Rengena Chan-Ting, DO, CMD, FACOI Jenna D. Toniatti, PharmD

Presented by Rengena Chan-Ting, DO, CMD, FACOI Jenna D. Toniatti, PharmD Presented by Rengena Chan-Ting, DO, CMD, FACOI Jenna D. Toniatti, PharmD Define BPSD and review the spectrum of associated symptoms Review pharmacologic and non-pharmacologic treatments for BPSD Evaluate

More information

9/11/2012. Clare I. Hays, MD, CMD

9/11/2012. Clare I. Hays, MD, CMD Clare I. Hays, MD, CMD Review regulatory background for current CMS emphasis on antipsychotics Understand the risks and (limited) benefits of antipsychotic medications Review non-pharmacologic management

More information

Antipsychotic Medications

Antipsychotic Medications TRAIL: Team Review of EVIDENCE REVIEW & RECOMMENDATIONS FOR LTC Behavioural and psychological symptoms of dementia (BPSD) refer to the non-cognitive symptoms of disturbed perception, thought content, mood

More information

Objectives. Antipsychotics 7/25/2016. LeadingAge Florida 53rd Annual Convention & Exposition

Objectives. Antipsychotics 7/25/2016. LeadingAge Florida 53rd Annual Convention & Exposition Reducing the Use of Antipsychotics in Long Term Care Communities Alan W. Obringer RPh, CPh, CGP Executive Director Senior Care Pharmacy Objectives Recognize the clinical evidence for the need to change

More information

Vanderbilt & Qsource Webinar Series

Vanderbilt & Qsource Webinar Series Vanderbilt & Qsource Webinar Series Vanderbilt Medical Center Vanderbilt University Center for Quality Aging Qsource Session #1: Introduction to Dementia Care & QAPI Session #2: Dementia & Behavioral Disturbances

More information

Organization: Sheppard Pratt Health System Solution Title: Lean Methodology: Appropriate Antipsychotic Use on an Inpatient Dementia Unit

Organization: Sheppard Pratt Health System Solution Title: Lean Methodology: Appropriate Antipsychotic Use on an Inpatient Dementia Unit Organization: Sheppard Pratt Health System Solution Title: Lean Methodology: Appropriate Antipsychotic Use on an Inpatient Dementia Unit Problem: For dementia patients, antipsychotic medications are prescribed

More information

Friend or Foe? Review of the Regulations & Benefits: Risk Profiles of the Benzodiazepines

Friend or Foe? Review of the Regulations & Benefits: Risk Profiles of the Benzodiazepines Friend or Foe? Review of the Regulations & Benefits: Risk Profiles of the Benzodiazepines Program Learning Objectives At the conclusion of the activity, participants should be able to: Have a basic understanding

More information

Improving Delirium Management: Mapping Out One Unit s Journey. Geriatrics Institute June 27, 2013

Improving Delirium Management: Mapping Out One Unit s Journey. Geriatrics Institute June 27, 2013 Improving Delirium Management: Mapping Out One Unit s Journey Geriatrics Institute June 27, 2013 Rebecca Ramsden, NP Mary Ann Hamelin, CNS Susanne Loay, RN Objectives Background RNAO Best Practice Guideline

More information

PSYCHOTROPIC SOLUTIONS

PSYCHOTROPIC SOLUTIONS PSYCHOTROPIC SOLUTIONS A proactive approach to antipsychotic medication management A Quality Use of Medicines initiative by Choice Aged Care Copyright 2018 Key Senate Committee Recommendations: All RACF

More information

A17/B17: Delirium Can Be Deadly: Save Lives With a Standardized Approach to Delirium IHI 25th Annual National Forum, December 10, 2013

A17/B17: Delirium Can Be Deadly: Save Lives With a Standardized Approach to Delirium IHI 25th Annual National Forum, December 10, 2013 A17/B17: Delirium Can Be Deadly: Save Lives With a Standardized Approach to Delirium IHI 25th Annual National Forum, December 10, 2013 Clay Angel, MD, Hospital Medicine; Chief of Continuum/SNF Kristen

More information

Making Sense of the Long Term Care Mega Rule: Unnecessary Drugs & Psychotropics. Session Objectives. January 2018

Making Sense of the Long Term Care Mega Rule: Unnecessary Drugs & Psychotropics. Session Objectives. January 2018 Making Sense of the Long Term Care Mega Rule: Unnecessary Drugs & Psychotropics Bridget McCrate Protus, PharmD, MLIS, BCGP, CDP Director of Drug Information Optum Hospice Pharmacy Services Session Objectives

More information

The place for treatments of associated neuropsychiatric and other symptoms

The place for treatments of associated neuropsychiatric and other symptoms The place for treatments of associated neuropsychiatric and other symptoms Luca Pani dg@aifa.gov.it London, 25 th November 2014 Workshop on Alzheimer s Disease European Medicines Agency London, UK Public

More information

PSYCHOTROPIC SOLUTIONS

PSYCHOTROPIC SOLUTIONS PSYCHOTROPIC SOLUTIONS A proactive approach to antipsychotic medication management A Quality Use of Medicines initiative by Choice Aged Care Copyright 2018 Hello everyone. Today we will be discussing the

More information

PSYCHOTROPIC MEDICATIONS IN LTC CHALLENGES AND OPPORTUNITIES FOR BEST PRACTICES

PSYCHOTROPIC MEDICATIONS IN LTC CHALLENGES AND OPPORTUNITIES FOR BEST PRACTICES PSYCHOTROPIC MEDICATIONS IN LTC CHALLENGES AND OPPORTUNITIES FOR BEST PRACTICES Coleen Kayden, RPh Medication Information Services Division of Williams Apothecary Conflicts of Interest None to report PANAC

More information

Antipsychotics for Dementia Under Control or Over-Prescribed?

Antipsychotics for Dementia Under Control or Over-Prescribed? Antipsychotics for Dementia Under Control or Over-Prescribed? Nathaniel Hedrick, PharmD ProCare HospiceCare, Manager of Clinical Services Learning Objectives Summarize the disease progression and most

More information

Improving Dementia Care in Nursing Homes Through Best Care Practices

Improving Dementia Care in Nursing Homes Through Best Care Practices Improving Dementia Care in Nursing Homes Through Best Care Practices Morris J. Kaplan, Esq., NHA President, Kaplan Health Management, LLC Operating Partner, Gwynedd Square Nursing Center 5 Star Rated by

More information

Use of Anti-Psychotic Agents in Irish Long Term Care Residents with Dementia

Use of Anti-Psychotic Agents in Irish Long Term Care Residents with Dementia Use of Anti-Psychotic Agents in Irish Long Term Care Residents with Dementia Aine Leen, Kieran Walsh, David O Sullivan, Denis O Mahony, Stephen Byrne, Margaret Bermingham Pharmaceutical Care Research Group,

More information

Preventing Falls in Older Adults A Matter of Safety

Preventing Falls in Older Adults A Matter of Safety Preventing Falls in Older Adults A Matter of Safety Roger Tam, BSc. Pharm. Wal-Mart Clinical Designated Pharmacist Falls Prevention Pharmacist Specialist NCCHC-Pre/Post Test Educator Q.U.I.T Educator Overview

More information

Transforming Care for the Elderly

Transforming Care for the Elderly Transforming Care for the Elderly Session 2: Engaging Pharmacists & Interdisciplinary Care Teams to Improve Prescribing of Antipsychotics & to Reduce Polypharmacy January 11, 2017 3 @cfhi_fcass Welcome

More information

Reducing Antipsychotic Drug Use in Long Term Care

Reducing Antipsychotic Drug Use in Long Term Care Reducing Antipsychotic Drug Use in Long Term Care Janice S. Ceriotti, RPh, CGP Director of Clinical Services Omnicare Pharmacies / Eastern MO Goals and Objectives Understand the history of Antipsychotics

More information

3/17/2017. Innovative Opportunities for Pharmacists in the Evolving World of Healthcare. Elderly represent about of our emergency medical services:

3/17/2017. Innovative Opportunities for Pharmacists in the Evolving World of Healthcare. Elderly represent about of our emergency medical services: Innovative Opportunities for Pharmacists in the Evolving World of Healthcare Christina Pornprasert, PharmD Population Health Clinical Pharmacist Hartford Healthcare Integrated Care Partners Addolorata

More information

Innovative Opportunities for Pharmacists in the Evolving World of Healthcare

Innovative Opportunities for Pharmacists in the Evolving World of Healthcare Innovative Opportunities for Pharmacists in the Evolving World of Healthcare Christina Pornprasert, PharmD Population Health Clinical Pharmacist Hartford Healthcare Integrated Care Partners Assistant Clinical

More information

DRAFT. Consultees are asked to consider and comment on the CEPP National Audit: Antipsychotics in Dementia document.

DRAFT. Consultees are asked to consider and comment on the CEPP National Audit: Antipsychotics in Dementia document. Enclosure No: Agenda item No: Author: Contact: xx/xxxxx/xxxx0918 xx CEPP National Audit: Antipsychotics in Dementia All Wales Therapeutics and Toxicology Centre Tel: 02920 71 6900 awttc@wales.nhs.uk 1.0

More information

Pharmacological Treatment of Behavioural and Psychological Symptoms of Dementia (BPSD) Gurdeep K Major St. Charles Hospital

Pharmacological Treatment of Behavioural and Psychological Symptoms of Dementia (BPSD) Gurdeep K Major St. Charles Hospital Pharmacological Treatment of Behavioural and Psychological Symptoms of Dementia (BPSD) Gurdeep K Major St. Charles Hospital with thanks to Jonathan Cavan for his input Aims Define BPSD and common symptoms

More information

Integrating INTERACT into Interim Pharmacist Reviews

Integrating INTERACT into Interim Pharmacist Reviews Integrating INTERACT into Interim Pharmacist Reviews Chad R. Worz, Pharm.D. President, Medication Managers, LLC Adjunct Assistant Professor of Pharmacy Practice, University of Cincinnati, College of Pharmacy

More information

Drugs used to relieve behavioural and psychological symptoms in dementia

Drugs used to relieve behavioural and psychological symptoms in dementia alzheimers.org.uk Drugs used to relieve behavioural and psychological symptoms in dementia People with dementia may develop behavioural and psychological symptoms including restlessness, aggression, delusions,

More information

Charles Bernick, MD, MPH Cleveland Clinic Lou Ruvo Center for Brain Health June 2, 2018

Charles Bernick, MD, MPH Cleveland Clinic Lou Ruvo Center for Brain Health June 2, 2018 Charles Bernick, MD, MPH Cleveland Clinic Lou Ruvo Center for Brain Health June 2, 2018 Delirium common Prolongs hospitalization Worsens dementia ( if you survive) Increased risk of institutionalization

More information

Workshop cases answers

Workshop cases answers Workshop cases answers BPSD Workshop: case histories Case 1: Mrs DM Scenario This is an 83 year old lady diagnosed with multi infarct dementia in 2008. Lives with husband and the couple are supported by

More information

Wicking Dementia Research & Education Centre, University of Tasmania, 2017

Wicking Dementia Research & Education Centre, University of Tasmania, 2017 Wicking Dementia Research & Education Centre, University of Tasmania, 2017 Westbury, J., Gee, P., Ling, T., Bindoff, I., Brown, D., Franks, K., Hoyle, D., Peterson, G. (2017). Reducing the Use of Sedative

More information

Managing challenging behaviours

Managing challenging behaviours Managing challenging behaviours Aims: Explore a selected psychosocial approach that may help to reduce the use of medication The positive and negative aspects of using the Newcastle model Look at how Newcastle

More information

Pharmacy Related Regulatory Changes in LTC. By: Anastasia Sidor, PharmD, BCGP Consultant Pharmacist Director Brockie Pharmatech

Pharmacy Related Regulatory Changes in LTC. By: Anastasia Sidor, PharmD, BCGP Consultant Pharmacist Director Brockie Pharmatech Pharmacy Related Regulatory Changes in LTC By: Anastasia Sidor, PharmD, BCGP Consultant Pharmacist Director Brockie Pharmatech Objectives 1. Contrast the difference between regulation and guidance within

More information

Update in Geriatrics: Choosing Wisely Primum Non Nocere

Update in Geriatrics: Choosing Wisely Primum Non Nocere Joseph G. Ouslander, M.D. Professor of Clinical Biomedical Science Senior Associate Dean for Geriatric Programs Chair, Department of Integrated Medical Science Charles E. Schmidt College of Medicine Professor

More information

Risks of Antipsychotics use In Dementia

Risks of Antipsychotics use In Dementia AHCA/NCAL Quality Initiative for Assisted Living Webinar Series: Safely Reducing the Off-Label Use of Antipsychotics Risks of Antipsychotics use In Dementia Sanjay P. Singh, MD Chairman & Professor, Department

More information

Behavioral Health Evaluation

Behavioral Health Evaluation This document is intended to serve as a template for a behavioral health committee meeting in an extended care facility. The State Operations Manual (SOM), Appendix PP - "Guidance to Surveyors for Long

More information

Guidelines for the Management of Behavioural and Psychological Symptoms of Dementia (BPSD) Summary document for Primary Care

Guidelines for the Management of Behavioural and Psychological Symptoms of Dementia (BPSD) Summary document for Primary Care Guidelines for the Management of Behavioural and Psychological Symptoms of Dementia (BPSD) Summary document for Primary Care Guidelines for the Management of Behavioural and Psychological Symptoms of Dementia

More information

New England QIN-QIO Reducing Unnecessary Antipsychotic Medications Affinity Group Call Thursday, January 19 th 3-4:00 pm. Presenters.

New England QIN-QIO Reducing Unnecessary Antipsychotic Medications Affinity Group Call Thursday, January 19 th 3-4:00 pm. Presenters. New England QIN-QIO Reducing Unnecessary Antipsychotic Medications Affinity Group Call Thursday, January 19 th 3-4:00 pm Call-In Information: 1-888-895-6448 Code: 7362894 Log-In Information: https://qualidigm.adobeconnect.com/affinity/

More information

Note: Attendees can earn up to 6.0 CPE Hours

Note: Attendees can earn up to 6.0 CPE Hours Texas ASCP Chapter Spring Continuing Education Program April 18, 2015 Texas Tech University Health Sciences Center * Dallas, TX School of Pharmacy- Dallas/Fort Worth 5920 Forest Park Road, Suite Note:

More information

Delirium. Dr. Lesley Wiesenfeld. Deputy Psychiatrist in Chief, Mount Sinai Hospital. Dr. Carole Cohen

Delirium. Dr. Lesley Wiesenfeld. Deputy Psychiatrist in Chief, Mount Sinai Hospital. Dr. Carole Cohen Delirium Dr. Lesley Wiesenfeld Deputy Psychiatrist in Chief, Mount Sinai Hospital Dr. Carole Cohen Department of Psychiatry, University of Toronto and Sunnybrook Health Sciences Centre Case Study Mrs B

More information

DEMENTIA and BPSD in PARKINSON'S DISEASE. DR. T. JOHNSON. NOVEMBER 2017.

DEMENTIA and BPSD in PARKINSON'S DISEASE. DR. T. JOHNSON. NOVEMBER 2017. DEMENTIA and BPSD in PARKINSON'S DISEASE. DR. T. JOHNSON. NOVEMBER 2017. Introduction. Parkinson's disease (PD) has been considered largely as a motor disorder. It has been increasingly recognized that

More information

CEPP National Audit Antipsychotics in Dementia

CEPP National Audit Antipsychotics in Dementia CEPP National Audit Antipsychotics in Dementia December 2018 This document has been prepared by a multiprofessional collaborative group, with support from the All Wales Prescribing Advisory Group (AWPAG)

More information

Reduction of High Risk Medications Using A Quality Initiative Perspective

Reduction of High Risk Medications Using A Quality Initiative Perspective Reduction of High Risk Medications Using A Quality Initiative Perspective Richard Mueller PharmD, MBA, MS, Director of Pharmacy Dianne Hempel BSN, RN Quality Improvement Coordinator Objectives Learn what

More information

5/17/2017. Conflicts of Interest. Key Takeaways

5/17/2017. Conflicts of Interest. Key Takeaways Antipsychotic Medications: The Balance Between Quality of Care and Quality of Life Coleen M Kayden, RPh Medication Information Services A Division of Williams Apothecary Pennsylvania Restraint Reduction

More information

Dementia: Reducing use of antipsychotics in patients with behavioural and psychological symptoms of dementia (BPSD) National & London Context

Dementia: Reducing use of antipsychotics in patients with behavioural and psychological symptoms of dementia (BPSD) National & London Context Dementia: Reducing use of antipsychotics in patients with behavioural and psychological symptoms of dementia (BPSD) National & London Context Lelly Oboh Consultant Pharmacist, Care of older people and

More information

Medicine Related Falls Risk Assessment Tool (MRFRAT)

Medicine Related Falls Risk Assessment Tool (MRFRAT) Medicine Related Falls Risk Assessment Tool (MRFRAT) The Medicine Related Falls Risk Assessment tool (MRFRAT) in Appendix 1 is designed to help identify patients at risk of falls due to their current medicine

More information

Psychiatric and Behavioral Symptoms in Alzheimer s and Other Dementias. Aaron H. Kaufman, MD

Psychiatric and Behavioral Symptoms in Alzheimer s and Other Dementias. Aaron H. Kaufman, MD Psychiatric and Behavioral Symptoms in Alzheimer s and Other Dementias Aaron H. Kaufman, MD Psychiatric and Behavioral Symptoms in Alzheimer s and Other Dementias Aaron H. Kaufman, M.D. Health Sciences

More information

The audit is managed by the Royal College of Psychiatrists in partnership with:

The audit is managed by the Royal College of Psychiatrists in partnership with: Background The National Audit of Dementia (NAD) care in general hospitals is commissioned by the Healthcare Quality Improvement Partnership on behalf of NHS England and the Welsh Government, as part of

More information

MORTALITY ASSOCIATED WITH USE OF ANTIPSYCHOTICS IN DEMENTIA: REVIEWING THE EVIDENCE

MORTALITY ASSOCIATED WITH USE OF ANTIPSYCHOTICS IN DEMENTIA: REVIEWING THE EVIDENCE MORTALITY ASSOCIATED WITH USE OF ANTIPSYCHOTICS IN DEMENTIA: REVIEWING THE EVIDENCE KRISTA L. LANCTÔT, PHD PROFESSOR OF PSYCHIATRY AND PHARMACOLOGY, UNIVERSITY OF TORONTO; SENIOR SCIENTIST, HURVITZ BRAIN

More information

Disclosure. Speaker Bureaus. Grant Support. Pfizer Forest Norvartis. Pan American Health Organization/WHO NIA HRSA

Disclosure. Speaker Bureaus. Grant Support. Pfizer Forest Norvartis. Pan American Health Organization/WHO NIA HRSA Disclosure Speaker Bureaus Pfizer Forest Norvartis Grant Support Pan American Health Organization/WHO NIA HRSA How Common is Psychosis in Alzheimer s Disease? Review of 55 studies 41% of those with Alzheimer

More information

Pharmacological Treatment of Aggression in the Elderly

Pharmacological Treatment of Aggression in the Elderly Pharmacological Treatment of Aggression in the Elderly Howard Fenn, MD Adjunct Clinical Associate Professor Department of Psychiatry and Behavioral Sciences Stanford University Self-Assessment Question

More information

nicheprogram.org 16th Annual NICHE Conference Forging New Paths and Partnerships 1

nicheprogram.org 16th Annual NICHE Conference Forging New Paths and Partnerships 1 Improving Patient Outcomes in Geriatric Post-Operative Orthopedic Patients: Translating Research into Practice Tripping into The CAM Presented by: Diana LaBumbard, RN, MSN, ACNP/GNP-BC, CWOCN Denise Williams,

More information

12/17/2012. Unnecessary Drugs

12/17/2012. Unnecessary Drugs Nursing Home Social Work Webinar Series December 19, 2012 Dr. Robin P. Bonifas, PhD, MSW Arizona State University School of Social Work Importance of familiarity with psychotropic medication regulations.

More information

FL Medicaid Drug Therapy Management Program for Behavioral Health Monitoring for Safety and Quality

FL Medicaid Drug Therapy Management Program for Behavioral Health Monitoring for Safety and Quality FL Medicaid Drug Therapy Management Program for Behavioral Health Monitoring for Safety and Quality April 23, 2014 Pensacola, FL Presentation Objectives To briefly describe the program and how its components

More information

Psychosis and Agitation in Dementia

Psychosis and Agitation in Dementia Psychosis and Agitation in Dementia Dilip V. Jeste, MD Estelle & Edgar Levi Chair in Aging, Director, Stein Institute for Research on Aging, Distinguished Professor of Psychiatry & Neurosciences, University

More information

Delirium in the Elderly

Delirium in the Elderly Delirium in the Elderly ELITE 2015 Mamata Yanamadala M.B.B.S, MS Division of Geriatrics Why should we care about delirium? It is: common associated with high mortality associated with increased morbidity

More information

Plante Moran Clinical Group

Plante Moran Clinical Group Handouts Prepared By: Jane Belt, MS, RN, RAC-MT Plante Moran Clinical Group jane.belt@ 2 Plante Moran Clinical Group 2013 1 Objectives Delineate the key requirements in F329 Unnecessary Medications Describe

More information

Delirium in the Elderly

Delirium in the Elderly Delirium in the Elderly ELITE 2017 Liza Genao, MD Division of Geriatrics Why should we care about delirium? It is: common associated with high mortality associated with increased morbidity Very much under-recognized

More information

Reducing Antipsychotics for Better Patient Outcomes. Care Providers Oklahoma Annual Fall Fair Sept. 18, 2018

Reducing Antipsychotics for Better Patient Outcomes. Care Providers Oklahoma Annual Fall Fair Sept. 18, 2018 Reducing Antipsychotics for Better Patient Outcomes Care Providers Oklahoma Annual Fall Fair Sept. 18, 2018 Agenda and Objectives Review mechanisms of action, clinical characteristics and safety information

More information

-Guidelines for the discontinuation of oral antipsychotics in patients with BPSD within the primary care setting Summary- Quetiapine

-Guidelines for the discontinuation of oral antipsychotics in patients with BPSD within the primary care setting Summary- Quetiapine -Guidelines for the discontinuation of oral antipsychotics in patients with BPSD within the primary care setting Summary- Quetiapine An independent report Time for action 1 by Professor Sube Banerjee looked

More information

Please Join Us. International Psychogeriatric Association. Dependency Ratio. Geriatric Psychiatry in the 21st Century: A Global Perspective

Please Join Us. International Psychogeriatric Association. Dependency Ratio. Geriatric Psychiatry in the 21st Century: A Global Perspective International Psychogeriatric Association Please Join Us Geriatric Psychiatry in the 21st Century: A Global Perspective Jacobo Mintzer M.D. Executive Director Roper Saint Frances Clinical and Biotechnology

More information

The Basics of Psychoactive/Psychotropic Medications Tina Sanchez, RN, SMQT New Mexico Department of Health Division of Health Improvement State

The Basics of Psychoactive/Psychotropic Medications Tina Sanchez, RN, SMQT New Mexico Department of Health Division of Health Improvement State The Basics of Psychoactive/Psychotropic Medications Tina Sanchez, RN, SMQT New Mexico Department of Health Division of Health Improvement State RAI/MDS Coordinator Objectives Upon completion of this training,

More information

NEW FEDERAL REGULATIONS Final Rule, Phase 2 (11/28/17)

NEW FEDERAL REGULATIONS Final Rule, Phase 2 (11/28/17) NEW FEDERAL REGULATIONS Final Rule, Phase 2 (11/28/17) F757- Drug Regimen is Free From Unnecessary Drugs 483.45(d) Unnecessary Drugs General Each resident s drug regimen must be free from unnecessary drugs.

More information

A Systematic Approach to

A Systematic Approach to A Systematic Approach to Drug Regimen Review REVISITING INTRODUCTION This article is the third in a threepart series exploring drug regimen review (DRR) over the last 30 years. In the first part, we explored

More information

Antipsychotics Detect, Select, Effect (P.I.E.C.E.S. 6 th Ed)

Antipsychotics Detect, Select, Effect (P.I.E.C.E.S. 6 th Ed) Antipsychotics Detect, Select, Effect (P.I.E.C.E.S. 6 th Ed) CLeAR Webinar February 14, 2014 Paula Diaz (Pharm) Carol Ward MD Carol Ward Tertiary Mental Health IHA Hillside Centre (Acute Tertiary Mental

More information

Dementia Care Principles

Dementia Care Principles New CMS Surveyor Guidance: Care & Services for a Resident with Dementia Cat Selman, BS www.thehealthcarecommunicators.com 2015 The Healthcare Communicators, Inc. All rights reserved. Dementia Care Principles

More information

Full details and resource documents available:

Full details and resource documents available: Clinical & Regulatory News by Pharmerica Urinary Tract Infection (UTI) Second Most Common Cause of Hospital Readmission within 30 days UTIs are prevalent and account for up to 22% of infections in LTC,

More information

Appendix 2017UEMS031

Appendix 2017UEMS031 Appendix 2017UEMS031 PREVENTION Clinical checklist This checklist should be completed for each person with dementia. Keep this chart with the person s corresponding paperwork. General symptoms Include

More information

GERIATRICS 101. Victoria L. Braund, MD, FACP, CMD. Director, Division of Geriatrics, NorthShore Medical Director, Symphony of Evanston

GERIATRICS 101. Victoria L. Braund, MD, FACP, CMD. Director, Division of Geriatrics, NorthShore Medical Director, Symphony of Evanston GERIATRICS 101 Victoria L. Braund, MD, FACP, CMD Director, Division of Geriatrics, NorthShore Medical Director, Symphony of Evanston LET S REVIEW Medicare Hospice Pain mgmt. Bowel business Delirium Sleep

More information

Reducing Falls Causing Harm in Older People with Dementia. Professor Tony Elliott South Staffordshire and Shropshire FT

Reducing Falls Causing Harm in Older People with Dementia. Professor Tony Elliott South Staffordshire and Shropshire FT Reducing Falls Causing Harm in Older People with Dementia Professor Tony Elliott South Staffordshire and Shropshire FT Project Site 16 bedded Dementia Inpatient Unit Acute admissions from home, DGHs or

More information

Multi-morbidity in Dementia: A 21st Century Challenge. Sube Banerjee. Professor of Dementia Brighton and Sussex Medical School

Multi-morbidity in Dementia: A 21st Century Challenge. Sube Banerjee. Professor of Dementia Brighton and Sussex Medical School Multi-morbidity in Dementia: A 21st Century Challenge Sube Banerjee Professor of Dementia Brighton and Sussex Medical School Most people of any age with any long term condition have multiple conditions

More information

Optimal Management of Challenging Behaviours in Dementia: An Update on Pharmacologic and Non-Pharmacologic Approaches

Optimal Management of Challenging Behaviours in Dementia: An Update on Pharmacologic and Non-Pharmacologic Approaches Optimal Management of Challenging Behaviours in Dementia: An Update on Pharmacologic and Non-Pharmacologic Approaches Andrea Iaboni, MD, DPhil, FRCPC Toronto Rehab Institute, UHN Learning objectives Recognize

More information

Platforms for Performance: Clinical Dashboards to Improve Quality and Safety 2011 Midyear Clinical Meeting

Platforms for Performance: Clinical Dashboards to Improve Quality and Safety 2011 Midyear Clinical Meeting Improving Mental Health Outcomes in Veterans Through Dashboard Technology Learning Objectives 1. Describe VA Academic Detailing 2. Show how an increase in metabolic monitoring and a decrease in off-label

More information

Antipsychotics in Dementia

Antipsychotics in Dementia Antipsychotics in Dementia What s all the fuss? Judy MacDonald RPh BSc Pharm Dr. Ashok Krishnamoorthy MD MRCPsych FRCPC ABAM MS (Neuro Psych) Learning Objectives Recognize common behavioural & psychological

More information

Recognition and Management of Behavioral Disturbances in Dementia

Recognition and Management of Behavioral Disturbances in Dementia Recognition and Management of Behavioral Disturbances in Dementia Danielle Hansen, DO, MS (Med Ed), MHSA INTRODUCTION 80% 90% of patients with dementia develop at least one behavioral disturbances or psychotic

More information

Learning Objectives. Delirium. Delirium. Delirium. Terminal Restlessness 3/28/2016

Learning Objectives. Delirium. Delirium. Delirium. Terminal Restlessness 3/28/2016 Terminal Restlessness Dr. Christopher Churchill St. Cloud VA Health Care System EC&R Service Line Director & Medical Director Hospice & Palliative Care March 31, 2016 Learning Objectives Different Terminology

More information

BEHAVIOURAL AND PSYCHOLOGICAL SYMPTOMS IN DEMENTIA

BEHAVIOURAL AND PSYCHOLOGICAL SYMPTOMS IN DEMENTIA BEHAVIOURAL AND PSYCHOLOGICAL SYMPTOMS IN DEMENTIA Unmet needs What might be your behavioural response to this experience? Content Definition What are BPSD? Prevalence How common are they? Aetiological

More information

Delirium. Quick reference guide. Issue date: July Diagnosis, prevention and management

Delirium. Quick reference guide. Issue date: July Diagnosis, prevention and management Issue date: July 2010 Delirium Diagnosis, prevention and management Developed by the National Clinical Guideline Centre for Acute and Chronic Conditions About this booklet This is a quick reference guide

More information

Outline. Disclosure. Sleep and the Elderly 1,2. Background

Outline. Disclosure. Sleep and the Elderly 1,2. Background Geriatric Grand Rounds Tuesday, March 31, 29 12: noon Dr. Bill Black Auditorium Glenrose Rehabilitation Hospital In keeping with Glenrose Rehabilitation Hospital policy, speakers participating in this

More information

Older People Mental Health - new directorate/new plans. Dr Adrian Treloar Clinical director

Older People Mental Health - new directorate/new plans. Dr Adrian Treloar Clinical director Older People Mental Health - new directorate/new plans Dr Adrian Treloar Clinical director Dementia 700,000 people in the UK currently have dementia; this number is set to double by 2038 1/3 of people

More information

Geriatric Pharmacology

Geriatric Pharmacology Geriatric Pharmacology Janice Scheufler R.Ph.,PharmD, FASCP Clinical Pharmacist Hospice of the Western Reserve Objectives List three risk factors for adverse drug events in the elderly Discuss two physiological

More information

483.45(d) Unnecessary Drugs General. Each resident s drug regimen must be free from unnecessary drugs. An unnecessary drug is any drug when used

483.45(d) Unnecessary Drugs General. Each resident s drug regimen must be free from unnecessary drugs. An unnecessary drug is any drug when used F757 483.45(d) Unnecessary Drugs General. Each resident s drug regimen must be free from unnecessary drugs. An unnecessary drug is any drug when used 483.45(d)(1) In excessive dose (including duplicate

More information

From the Front Lines AlixaRx Clinical Pharmacists Address Everyday Challenges in Long-Term Care

From the Front Lines AlixaRx Clinical Pharmacists Address Everyday Challenges in Long-Term Care May 2015 Issue From the Front Lines AlixaRx Clinical Pharmacists Address Everyday Challenges in Long-Term Care Behavior Monitoring When is behavior monitoring required? In Long-term care, medications are

More information

Olanzapine Long-Acting Injection (Zypadhera ) - Guidelines for Prescribing and Administration (Version 3 May 2015)

Olanzapine Long-Acting Injection (Zypadhera ) - Guidelines for Prescribing and Administration (Version 3 May 2015) 1. Key Points Olanzapine Long-Acting Injection (Zypadhera ) - Guidelines for Prescribing and Administration (Version 3 May 2015) 1.1 Olanzapine long acting injection (LAI) is indicated for the maintenance

More information

Thank You to Our Sponsors: Evaluations & CE Credits. Featured Speakers. Conflict of Interest & Disclosure Statements 10/18/2016

Thank You to Our Sponsors: Evaluations & CE Credits. Featured Speakers. Conflict of Interest & Disclosure Statements 10/18/2016 Thank You to Our Sponsors: University at Albany School of Public Health NYS Department of Health Conflict of Interest & Disclosure Statements The planners and presenters do not have any financial arrangements

More information

Fighting the Fog A Collaborative Approach to Decreasing ICU Delirium

Fighting the Fog A Collaborative Approach to Decreasing ICU Delirium Fighting the Fog A Collaborative Approach to Decreasing ICU Delirium Kimberly Scherr NP Jennifer Barker RN Misericordia Hospital ICU Edmonton, AB CACCN Dynamics Sept 21, 2014 Delirium Delirium is an acute

More information

WHAT NONPHYSICIAN PROVIDERS CAN DO FOR YOUR FRAGILITY FRACTURE SERVICE

WHAT NONPHYSICIAN PROVIDERS CAN DO FOR YOUR FRAGILITY FRACTURE SERVICE WHAT NONPHYSICIAN PROVIDERS CAN DO FOR YOUR FRAGILITY FRACTURE SERVICE Debra L. Sietsema, PhD, RN October 7, 2016 OTA Meeting 1 Disclosures Speaker and Consultant: Lilly USA Committee Member: AOA Own the

More information

Safety Profile Assessment of Risperidone and Olanzapine in Long-Term Care Patients with Dementia

Safety Profile Assessment of Risperidone and Olanzapine in Long-Term Care Patients with Dementia ORIGINAL STUDIES Safety Profile Assessment of Risperidone and Olanzapine in Long-Term Care Patients with Dementia Harlan Martin, RPh, CCP, FASCP, Michael P. Slyk, PharmD, FASCP, Sheila Deymann, PharmD,

More information

Up to 90% of people with dementia experience

Up to 90% of people with dementia experience Focus on CME at the University of Calgary Getting Aggressive with Dementia Adrienne Cohen, MD, BSc, FRCPC Presented at Behaviour Problems in the Elderly, video-audio conference, 2003 Up to 90% of people

More information

COMBATTING THE EXCESSIVE AND ILLEGAL USE OF PSYCHOTROPIC DRUGS ON PEOPLE WITH DEMENTIA IN NURSING FACILITIES

COMBATTING THE EXCESSIVE AND ILLEGAL USE OF PSYCHOTROPIC DRUGS ON PEOPLE WITH DEMENTIA IN NURSING FACILITIES COMBATTING THE EXCESSIVE AND ILLEGAL USE OF PSYCHOTROPIC DRUGS ON PEOPLE WITH DEMENTIA IN NURSING FACILITIES Kelly Bagby and Iris Gonzalez kbagby@aarp.org (202) 434-2103 igonzalez@aarp.org (202) 434-6289

More information

MOQI. What is MOQI? ! One of seven grants awarded across the country to reduce unnecessary transfers from LTC to hospitals

MOQI. What is MOQI? ! One of seven grants awarded across the country to reduce unnecessary transfers from LTC to hospitals Aging America: Caring for our Elders MOAPA CONFERENCE JUNE 26, 2017 JOANN FRANKLIN, DNP, GNP-BC, FNP-BC, MHNP, FAANP MOQI ADVANCED PRACTICE RN FRANKLINJB@MISSOURI.EDU What is MOQI?! CMS Initiative to Reduce

More information

Pain: Facility Assessment Checklists

Pain: Facility Assessment Checklists Pain: Facility Assessment Checklists This is a series of self-assessment checklists for nursing home staff to use to assess processes related to pain management in the facility and to identify areas that

More information

Management of the Acutely Agitated Long Term Care Patient

Management of the Acutely Agitated Long Term Care Patient Management of the Acutely Agitated Long Term Care Patient 80 60 Graying of the Population US Population Over Age 65 Millions of Persons 40 20 0 1900 1920 1940 1960 1980 1990 2010 2030 Year Defining Dementia

More information

Supporting and Caring in Dementia

Supporting and Caring in Dementia Supporting and Caring in Dementia Surrey and Sussex Healthcare, Delivering the National Dementia Strategy Strategy and Implementation Plan Final November 2011 1 National Strategy The National Dementia

More information

Why New Thinking is Needed for Older Adults across the Rehabilitation Continuum

Why New Thinking is Needed for Older Adults across the Rehabilitation Continuum Why New Thinking is Needed for Older Adults across the Rehabilitation Continuum Samir K. Sinha MD, DPhil, FRCPC Director of Geriatrics Mount Sinai and the University Health Network Hospitals Assistant

More information

Residents Who Don t Sleep

Residents Who Don t Sleep Residents Who Don t Sleep Case study........................................... An 86 yr. old woman has diagnoses of Alzheimer s disease, congestive heart failure, constipation, depression, hypertension

More information

Summary of Delirium Clinical Practice Guideline Recommendations Post Operative

Summary of Delirium Clinical Practice Guideline Recommendations Post Operative Summary of Delirium Clinical Practice Guideline Recommendations Post Operative Intensive Care Unit Clinical Practice Guideline for Postoperative Clinical Practice Guidelines for the Delirium in Older Adults;

More information

Palliative Care Consult Service

Palliative Care Consult Service Creating Program Elements to Improve the Care of the Dementia Patient in Palliative & Hospice Settings Carla Jolley MN, ARNP, ANP-BC, AOCN, ACHPN Palliative Care APN/Program Coordinator WhidbeyHealth Palliative

More information

How to disseminate the Acute Care for Elders (ACE) model of care beyond one unit

How to disseminate the Acute Care for Elders (ACE) model of care beyond one unit How to disseminate the Acute Care for Elders (ACE) model of care beyond one unit Roger Wong, BMSc, MD, FRCPC, FACP Clinical Professor, Division of Geriatric Medicine Associate Dean, Postgraduate Medical

More information

FALLS PREVENTION. S H I R L E Y H U A N G, M S c, M D, F R C P C

FALLS PREVENTION. S H I R L E Y H U A N G, M S c, M D, F R C P C FALLS PREVENTION S H I R L E Y H U A N G, M S c, M D, F R C P C S T A F F G E R I A T R I C I A N T H E O T T A W A H O S P I T A L B R U Y E R E C O N T I N U I N G C A R E W I N C H E S T E R D I S T

More information